<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer Japan</PublisherName>
    <PublisherLocation>Japan</PublisherLocation>
  </PublisherInfo>
  <Journal OutputMedium="Online">
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>10047</JournalID>
      <JournalPrintISSN>1434-7229</JournalPrintISSN>
      <JournalElectronicISSN>1619-0904</JournalElectronicISSN>
      <JournalTitle>Journal of Artificial Organs</JournalTitle>
      <JournalSubTitle>The Official Journal of the Japanese Society for Artificial Organs</JournalSubTitle>
      <JournalAbbreviatedTitle>J Artif Organs</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Type="Primary">Medicine &amp; Public Health</JournalSubject>
        <JournalSubject Type="Secondary">Hepatology </JournalSubject>
        <JournalSubject Type="Secondary">Nephrology </JournalSubject>
        <JournalSubject Type="Secondary">Orthopedics </JournalSubject>
        <JournalSubject Type="Secondary">Biomedical Engineering</JournalSubject>
        <JournalSubject Type="Secondary">Cardiac Surgery </JournalSubject>
        <JournalSubject Type="Secondary">Surgery </JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume OutputMedium="All">
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>11</VolumeIDStart>
        <VolumeIDEnd>11</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular" OutputMedium="Online">
        <IssueInfo IssueType="Regular" TocLevels="0">
          <IssueIDStart>4</IssueIDStart>
          <IssueIDEnd>4</IssueIDEnd>
          <IssueArticleCount>12</IssueArticleCount>
          <IssueHistory>
            <OnlineDate>
              <Year>2008</Year>
              <Month>12</Month>
              <Day>17</Day>
            </OnlineDate>
            <CoverDate>
              <Year>2008</Year>
              <Month>12</Month>
            </CoverDate>
            <PricelistYear>2008</PricelistYear>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>The Japanese Society for Artificial Organs</CopyrightHolderName>
            <CopyrightYear>2008</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="s10047-008-0436-1" OutputMedium="All">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>436</ArticleID>
            <ArticleDOI>10.1007/s10047-008-0436-1</ArticleDOI>
            <ArticleSequenceNumber>10</ArticleSequenceNumber>
            <ArticleTitle Language="En">Standardization for mass production of allogeneic cultured dermal substitute by measuring the amount of VEGF, bFGF, HGF, TGF-β, and IL-8</ArticleTitle>
            <ArticleCategory>Original Article</ArticleCategory>
            <ArticleFirstPage>225</ArticleFirstPage>
            <ArticleLastPage>231</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>12</Month>
                <Day>16</Day>
              </RegistrationDate>
              <Received>
                <Year>2008</Year>
                <Month>4</Month>
                <Day>4</Day>
              </Received>
              <Accepted>
                <Year>2008</Year>
                <Month>9</Month>
                <Day>24</Day>
              </Accepted>
              <OnlineDate>
                <Year>2008</Year>
                <Month>12</Month>
                <Day>17</Day>
              </OnlineDate>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>The Japanese Society for Artificial Organs</CopyrightHolderName>
              <CopyrightYear>2008</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Akiko</GivenName>
                  <FamilyName>Hashimoto</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Yoshimitsu</GivenName>
                  <FamilyName>Kuroyanagi</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>+81-42-778-9710</Phone>
                  <Fax>+81-42-778-9710</Fax>
                  <Email>kuroyana@ahs.kitasato-u.ac.jp</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Research and Development Center for Artificial Skin, School of Allied Health Sciences</OrgDivision>
                <OrgName>Kitasato University</OrgName>
                <OrgAddress>
                  <Street>1-15-1 Kitasato, Sagamihara</Street>
                  <City>Kanagawa</City>
                  <Postcode>228-8555</Postcode>
                  <Country Code="JP">Japan</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Fibroblasts were isolated from a piece of donated skin measuring about 1 × 1 cm and were proliferated over nine successive cultivations. Fibroblasts obtained from the fourth cultivation were cryopreserved in 10 cryotubes as master cells. Fibroblasts obtained from the fifth to ninth cultivations were cryopreserved in 49 cryotubes in total as working cells. At the end of each procedure in the fourth to eighth cultivations, about three-quarters of the proliferated fibroblasts were cryopreserved, and the remaining one-quarter were proliferated in the next cultivation. All fibroblasts obtained from the ninth (final) procedure were cryopreserved as the last working cells. Two cryotubes of the last cryopreserved working cells (ninth cultivation) were thawed and proliferated. Cultured dermal substitute (CDS) was prepared by performing ten successive cultivations. After each cultivation, about three-quarters of the resulting fibroblasts were used to prepare CDS, and the remaining one-quarter were proliferated in the next cultivation for 1 week. Finally, all fibroblasts produced by the tenth (final) procedure were used to prepare CDS. In each of the first to ninth cultivations for CDS preparation, the density of fibroblasts remained relatively constant, and the levels of cytokines, i.e., vascular endothelial growth factor, basic fibroblast growth factor, hepatocyte growth factor, transforming growth factor-beta 1, and interleukin-8 released from CDS remained relatively constant. In total, 47 sheets of CDS measuring 10 × 10 cm were prepared. The present findings indicate that about 1000 sheets of CDS measuring 10 × 10 cm can be prepared using all the working cells prepared from a piece of donated skin measuring 1 × 1 cm.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Key words</Heading>
              <Keyword>Allogeneic cultured dermal substitute</Keyword>
              <Keyword>Hyaluronic acid</Keyword>
              <Keyword>Collagen</Keyword>
              <Keyword>Growth factor</Keyword>
            </KeywordGroup>
          </ArticleHeader>
          <BodyRef TargetType="OnlinePDF" FileRef="BodyRef/PDF/10047_2008_Article_436.pdf"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T.B.</Initials>
                    <FamilyName>Boyce</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Design principles for composition and performance of cultured skin substitutes</ArticleTitle>
                  <JournalTitle>Burns</JournalTitle>
                  <VolumeID>27</VolumeID>
                  <FirstPage>523</FirstPage>
                  <LastPage>533</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11451611</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0305-4179(01)00019-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3MvgtVegtA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Boyce TB. Design principles for composition and performance of cultured skin substitutes. Burns 2001;27:523–533</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelocollagen combined with fibroblasts: fundamental evaluation</ArticleTitle>
                  <JournalTitle>J Biomater Sci Polymer Edn</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>625</FirstPage>
                  <LastPage>641</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1163/156856203322274897</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmtFeht7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kubo K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelocollagen combined with fibroblasts: fundamental evaluation. J Biomater Sci Polymer Edn 2003;14:625–641</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test</ArticleTitle>
                  <JournalTitle>J Artif Organs</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>64</FirstPage>
                  <LastPage>70</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14598127</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s100470300010</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXivFygt78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kubo K, Kuroyanagi Y. Spongy matrix of hyaluronic acid and collagen as a cultured dermal substitute: evaluation in an animal test. J Artif Organs 2003;6:64–70</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts</ArticleTitle>
                  <JournalTitle>J Artif Organs</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>138</FirstPage>
                  <LastPage>144</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14598115</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXkvFyjsbY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kubo K, Kuroyanagi Y. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J Artif Organs 2003;6:138–144</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro</ArticleTitle>
                  <JournalTitle>J Artif Organs</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>267</FirstPage>
                  <LastPage>272</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14691669</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s10047-003-0239-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXhtVSjsb%2FE</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kubo K, Kuroyanagi Y. Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro. J Artif Organs 2003;6:267–272</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Matsui</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.J.</Initials>
                    <FamilyName>Kim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Numari</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Mabuchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Kagawa</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Establishment of banking system for allogeneic cultured dermal substitute</ArticleTitle>
                  <JournalTitle>Artif Organs</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>13</FirstPage>
                  <LastPage>21</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14720283</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1525-1594.2004.07318.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kuroyanagi Y, Kubo K, Matsui H, Kim HJ, Numari S, Mabuchi Y, Kagawa S. Establishment of banking system for allogeneic cultured dermal substitute. Artif Organs 2004;28:13–21</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelocollagen combined with fibroblasts: cryopreservation</ArticleTitle>
                  <JournalTitle>Artif Organs</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>182</FirstPage>
                  <LastPage>188</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14961958</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1525-1594.2004.47219.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kubo, K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelocollagen combined with fibroblasts: cryopreservation. Artif Organs 2004;28:182–188</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">The possibility of long-term cryopreservation of cultured dermal subsitute</ArticleTitle>
                  <JournalTitle>Artif Organs</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>800</FirstPage>
                  <LastPage>805</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16185341</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1525-1594.2005.00132.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtF2ju7nI</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kubo K, Kuroyanagi Y. The possibility of long-term cryopreservation of cultured dermal subsitute. Artif Organs 2005;29:800–805</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">A study of cytokines released from fibroblasts in cultured dermal subsitute</ArticleTitle>
                  <JournalTitle>Artif Organs</JournalTitle>
                  <VolumeID>29</VolumeID>
                  <FirstPage>845</FirstPage>
                  <LastPage>849</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16185348</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1525-1594.2005.00138.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtF2ju7bJ</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kubo K, Kuroyanagi Y. A study of cytokines released from fibroblasts in cultured dermal subsitute. Artif Organs 2005;29:845–849</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Kashiwa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O.</Initials>
                    <FamilyName>Ito</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Ueda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Matsui</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Treatment of full-thickness skin defect with concomitant grafting of sixfold extended mesh auto-skin and allogeneic cultured dermal substitute</ArticleTitle>
                  <JournalTitle>Artif Organs</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>444</FirstPage>
                  <LastPage>450</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15113338</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1525-1594.2004.00009.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kashiwa N, Ito O, Ueda T, Kubo K, Matsui H, Kuroyanagi Y. Treatment of full-thickness skin defect with concomitant grafting of sixfold extended mesh auto-skin and allogeneic cultured dermal substitute. Artif Organs 2004;28:444–450</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Ohtani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Okamoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Kaminaka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Kishi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Sakurane</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Yamamoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Ueda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Furukawa</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS)</ArticleTitle>
                  <JournalTitle>Eur J Dermatol</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>168</FirstPage>
                  <LastPage>171</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15246943</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ohtani T, Okamoto K, Kaminaka C, Kishi T, Sakurane M, Yamamoto Y, Ueda K, Kubo K, Kuroyanagi Y, Furukawa F. Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS). Eur J Dermatol 2004;14:168–171</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Moroi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Fujita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Fukagawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Mashino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Goto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Masuda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Urabe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Matsui</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Kagawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Furue</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection</ArticleTitle>
                  <JournalTitle>Eur J Dermatol</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>172</FirstPage>
                  <LastPage>176</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15246944</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Moroi Y, Fujita S, Fukagawa S, Mashino T, Goto T, Masuda T, Urabe K, Kubo K, Matsui H, Kagawa S, Kuroyanagi Y, Furue M. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection. Eur J Dermatol 2004;14:172–176</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Hasegawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Suga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Mizoguchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Ikeda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Ogawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Matsui</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Kagawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in three patients with recessive dystrophic epidermolysis bullosa</ArticleTitle>
                  <JournalTitle>J Am Acad Dermatol</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <FirstPage>803</FirstPage>
                  <LastPage>804</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15097978</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.jaad.2003.08.013</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hasegawa T, Suga Y, Mizoguchi M, Ikeda S, Ogawa H, Kubo K, Matsui H, Kagawa S, Kuroyanagi Y. Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in three patients with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol 2004;50:803–804</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Hasegawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Suga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Mizoguchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Muramatsu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Minuzo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Ogawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports</ArticleTitle>
                  <JournalTitle>J Dermatol</JournalTitle>
                  <VolumeID>32</VolumeID>
                  <FirstPage>715</FirstPage>
                  <LastPage>720</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16361714</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1111/j.1346-8138.2005.tb00831.x</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Hasegawa T, Suga Y, Mizoguchi M, Muramatsu S, Minuzo Y, Ogawa H, Kubo K, Kuroyanagi Y. An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports. J Dermatol 2005;32:715–720</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Hasegawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Suga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Mizoguchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Muramatsu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Mizuno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Ikeda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Haruna</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Ogawa</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">A case of intractable venous leg ulcer treated successfully with allogeneic cultured dermal substitute</ArticleTitle>
                  <JournalTitle>Scand J Plast Reconstr Surg Hand Surg</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>326</FirstPage>
                  <LastPage>328</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17952802</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1080/02844310600723224</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hasegawa T, Suga Y, Mizoguchi M, Muramatsu S, Mizuno Y, Ikeda S, Haruna K, Kuroyanagi Y, Ogawa H. A case of intractable venous leg ulcer treated successfully with allogeneic cultured dermal substitute. Scand J Plast Reconstr Surg Hand Surg 2007;41:326–328</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Yonezawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Tanizaki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Inoguchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Ishida</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Katoh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Tachibana</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Miyachi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Kubo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers</ArticleTitle>
                  <JournalTitle>Int J Dermatol</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <FirstPage>36</FirstPage>
                  <LastPage>42</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17214717</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1365-4632.2007.03107.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yonezawa M, Tanizaki H, Inoguchi N, Ishida M, Katoh M, Tachibana T, Miyachi Y, Kubo K, Kuroyanagi Y. Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers. Int J Dermatol 2007;46:36–42</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Nishimoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Amoh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Tanabe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Niiyama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Katsuoka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kuroyanagi</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: treatment with allogeneic cultured dermal substitute</ArticleTitle>
                  <JournalTitle>Eur J Dermatol</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <FirstPage>350</FirstPage>
                  <LastPage>351</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17540657</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nishimoto J, Amoh Y, Tanabe K, Niiyama N, Katsuoka K, Kuroyanagi Y. Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: treatment with allogeneic cultured dermal substitute. Eur J Dermatol 2007;17:350–351</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Dijke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.K.</Initials>
                    <FamilyName>Iwata</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Growth factors for wound healing</ArticleTitle>
                  <JournalTitle>Biotechnology</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>793</FirstPage>
                  <LastPage>798</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nbt0889-793</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dijke P, Iwata KK. Growth factors for wound healing. Biotechnology 1989;7:793–798</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V.</Initials>
                    <FamilyName>Falanga</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Growth factors and wound healing</ArticleTitle>
                  <JournalTitle>J Dermatol Surg Oncol</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <FirstPage>711</FirstPage>
                  <LastPage>714</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8349910</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3szlt12msA%3D%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1111/j.1524-4725.1993.tb00414.x</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Falanga V. Growth factors and wound healing. J Dermatol Surg Oncol 1993;19:711–714</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V.</Initials>
                    <FamilyName>Moulin</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Growth factor in skin wound healing</ArticleTitle>
                  <JournalTitle>Eur J Cell Biology</JournalTitle>
                  <VolumeID>68</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>7</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXoslKlsbs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0006-3495(95)80233-X</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Moulin V. Growth factor in skin wound healing. Eur J Cell Biology 1995;68:1–7</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N.N.</Initials>
                    <FamilyName>Nissen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.J.</Initials>
                    <FamilyName>Polverini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Koch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.V.</Initials>
                    <FamilyName>Volin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.L.</Initials>
                    <FamilyName>Gamelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.A.</Initials>
                    <FamilyName>DiPietro</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing</ArticleTitle>
                  <JournalTitle>Am J Pathol</JournalTitle>
                  <VolumeID>152</VolumeID>
                  <FirstPage>1445</FirstPage>
                  <LastPage>1452</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9626049</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXktVSkurY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998;152:1445–1452</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C.J.</Initials>
                    <FamilyName>Corral</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Siddiqui</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Wu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.L.</Initials>
                    <FamilyName>Farrell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Lyons</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.A.</Initials>
                    <FamilyName>Mustoe</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing</ArticleTitle>
                  <JournalTitle>Arch Surg</JournalTitle>
                  <VolumeID>134</VolumeID>
                  <FirstPage>200</FirstPage>
                  <LastPage>205</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10025464</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1001/archsurg.134.2.200</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXhsFSgs7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Corral CJ, Siddiqui A, Wu L, Farrell CL, Lyons D, Mustoe TA. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg 1999;134:200–205</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Nayeri</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Stromberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Larsson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Brudin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Soderstrom</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Forsberg</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Hepatocyte growth factor may accelerate healing in chronic leg ulcers: pilot study</ArticleTitle>
                  <JournalTitle>J Dermatol Treat</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>81</FirstPage>
                  <LastPage>86</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1080/095466302317584449</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xmt1aitrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nayeri F, Stromberg T, Larsson M, Brudin L, Soderstrom C, Forsberg P. Hepatocyte growth factor may accelerate healing in chronic leg ulcers: pilot study. J Dermatol Treat 2002;13:81–86</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
